<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">25287</article-id><article-id pub-id-type="doi">10.7554/eLife.25287</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Synchronized HIV assembly by tunable PIP<sub>2</sub> changes reveals PIP<sub>2</sub> requirement for stable Gag anchoring</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-79944"><name><surname>Mücksch</surname><given-names>Frauke</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0132-5101</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21783"><name><surname>Laketa</surname><given-names>Vibor</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-79945"><name><surname>Müller</surname><given-names>Barbara</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5726-5585</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-11978"><name><surname>Schultz</surname><given-names>Carsten</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-16653"><name><surname>Kräusslich</surname><given-names>Hans-Georg</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8756-329X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Infectious Diseases, Virology</institution>, <institution>University Hospital Heidelberg</institution>, <addr-line><named-content content-type="city">Heidelberg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff2"><institution content-type="dept">Cell Biology and Biophysics Unit</institution>, <institution>European Molecular Biology Laboratory</institution>, <addr-line><named-content content-type="city">Heidelberg</named-content></addr-line>, <country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1190"><name><surname>Sundquist</surname><given-names>Wesley I</given-names></name><role>Reviewing editor</role><aff><institution>University of Utah School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>hans-georg.kraeusslich@med.uni-heidelberg.de</email> (HK);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>02</day><month>06</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e25287</elocation-id><history><date date-type="received"><day>20</day><month>01</month><year>2017</year></date><date date-type="accepted"><day>25</day><month>05</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Mücksch et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Mücksch et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-25287-v1.pdf"/><abstract><p>HIV-1 assembles at the plasma membrane (PM) of infected cells. PM association of the main structural protein Gag depends on its myristoylated MA domain and PM PI(4,5)P<sub>2</sub>. Using a novel chemical biology tool that allows rapidly tunable manipulation of PI(4,5)P<sub>2</sub> levels in living cells, we show that depletion of PI(4,5)P<sub>2</sub> completely prevents Gag PM targeting and assembly site formation. Unexpectedly, PI(4,5)P<sub>2</sub> depletion also caused loss of pre-assembled Gag lattices from the PM. Subsequent restoration of PM PI(4,5)P<sub>2</sub> reinduced assembly site formation even in the absence of new protein synthesis, indicating that the dissociated Gag molecules remained assembly competent. These results reveal an important role of PI(4,5)P<sub>2</sub> for HIV-1 morphogenesis beyond Gag recruitment to the PM and suggest a dynamic equilibrium of Gag-lipid interactions. Furthermore, they establish an experimental system that permits synchronized induction of HIV-1 assembly leading to induced production of infectious virions by targeted modulation of Gag PM targeting.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>TRR 83  project 14</award-id><principal-award-recipient><name><surname>Kräusslich</surname><given-names>Hans-Georg</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>TRR 83 project 2</award-id><principal-award-recipient><name><surname>Schultz</surname><given-names>Carsten</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB 1129 project 5</award-id><principal-award-recipient><name><surname>Kräusslich</surname><given-names>Hans-Georg</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB 1129 project 6</award-id><principal-award-recipient><name><surname>Müller</surname><given-names>Barbara</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>Excellence Cluster CellNetworks Exc81</award-id><principal-award-recipient><name><surname>Müller</surname><given-names>Barbara</given-names></name><name><surname>Kräusslich</surname><given-names>Hans-Georg</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009139</institution-id><institution>Deutsches Zentrum für Infektionsforschung</institution></institution-wrap></funding-source><award-id>Project 7.5 TTU HIV</award-id><principal-award-recipient><name><surname>Kräusslich</surname><given-names>Hans-Georg</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Carsten Schultz, C. Schultz is a shareholder of the company SiChem, which distributes rCDS.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-25287-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>